Trial intelligence / Profile preview

Vitamin C for Oral Mucositis in Head and Neck Cancer

NCT02868151Phase 3Completed

Sponsor
Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre
Start
Aug 2016
Primary completion
Dec 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial of ascorbic acid in oral mucositis (OM) (3 arms), sponsored by Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre. Primary endpoint: World Health Organization criteria of grading oral mucositis at 1.5 years. Started Aug 2016; status: completed.

02

Drugs

ascorbic acid
03

Conditions

oral mucositis (OM)

Beyond the preview

Go deeper on NCT02868151.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02868151.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call